15.11
Mineralys Therapeutics Inc (MLYS) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
-
|
- | - | - | - |
|
5.17%
46.75
|
44.45 | 60.11 | 45.17 | 35.36 |
Operating Income/Loss |
5.17%
-46.75
|
-44.45 | -60.11 | -45.17 | -35.36 |
Nonoperating Income/Loss |
55.28%
3.472
|
2.236 | 3.764 | 4.154 | 3.854 |
Income/Loss From Continuing Operations Before Tax |
2.52%
-43.27
|
-42.21 | -56.34 | -41.01 | -31.51 |
Income/Loss From Continuing Operations After Tax |
2.52%
-43.27
|
-42.21 | -56.34 | -41.01 | -31.51 |
|
2.52%
-43.27
|
-42.21 | -56.34 | -41.01 | -31.51 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
23.11%
65.45
|
53.16 | 49.82 | 49.36 | 44.90 |
Diluted Average Shares |
23.11%
65.45
|
53.16 | 49.82 | 49.36 | 44.90 |
Basic Earnings Per Share |
16.46%
-0.66
|
-0.79 | -1.13 | -0.83 | -0.70 |
Diluted Earnings Per Share |
16.46%
-0.66
|
-0.79 | -1.13 | -0.83 | -0.70 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):